作者: Navneet S. Majhail , Claudio G. Brunstein , John E. Wagner
DOI: 10.1016/J.COI.2006.07.015
关键词:
摘要: Unrelated umbilical cord blood (UCB) is an alternative donor source for allogeneic haematopoietic cell transplantation and, compared with unrelated bone marrow, has the advantages of rapid availability, greater tolerance HLA disparity and lower incidence severe graft-versus-host disease. Graft dose important determinant recovery overall outcome following UCB transplantation, limited single units been a major barrier to its more widespread use. Transplantation two feasible, safe effective can overcome limitation units.